Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management US$ 26.02 Min. order: 1 piece ★★★★★ 4.2 (15 reviews) Sold : Login>>
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants - Gabe - 2024 - Diabetes, Obesity and Metabolism US$ 24.12 Min. order: 1 piece ★★★★★ 4.0 (231 reviews) Sold : Login>>
BPC-157 Pure Immediate Release, 30 Capsules US$ 23.33 Min. order: 1 piece ★★★★★ 4.0 (110 reviews) Sold : Login>>
Novo's Phase 3 CagriSema results disappoint analysts, sending stock tumbling - MM+M US$ 21.29 Min. order: 1 piece ★★★★★ 4.1 (182 reviews) Sold : Login>>
Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept - Bhattachar - 2026 - Diabetes, Obesity and Metabolism US$ 23.74 Min. order: 1 piece ★★★★★ 4.3 (280 reviews) Sold : Login>>
Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 US$ 28.18 Min. order: 1 piece ★★★★★ 4.4 (201 reviews) Sold : Login>>